Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 34301-34350 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06099457
SIBTime Phase II: Web Application for Typically Developing Siblings
NA
Recruiting
160 participants
Started: Oct 27, 2023 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT06122558
Efficacy of Probiotic Against Functional Constipation
PHASE2
Recruiting
104 participants
Started: Oct 27, 2023 · Completed: Oct 26, 2025
1 condition
2 sponsors
2 locations
NCT05933083
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
NA
Recruiting
516 participants
Started: Oct 27, 2023 · Completed: Oct 15, 2027
6 conditions
6 sponsors
5 locations
NCT05786131
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NA
Recruiting
3,390 participants
Started: Oct 27, 2023 · Completed: Jul 31, 2027
2 conditions
5 sponsors
58 locations
NCT06078540
A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African Americans
NA
Recruiting
30 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2026
2 conditions
1 sponsor
1 location
NCT05658497
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
N/A
Recruiting
908 participants
Started: Oct 27, 2023 · Completed: Jul 6, 2032
1 condition
1 sponsor
7 locations
NCT06109064
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
PHASE2
Recruiting
14 participants
Started: Oct 27, 2023 · Completed: Feb 1, 2026
1 condition
1 sponsor
1 location
NCT06170411
Post-marketing Clinical Trial of Elexir(Trigeminal Nerve Electrical Stimulator) for the Acute Treatment of Migraine
NA
Recruiting
100 participants
Started: Oct 27, 2023 · Completed: Aug 1, 2024
1 condition
1 sponsor
2 locations
NCT06938464
Preventive Effect of Probiotics in GDM
NA
Recruiting
334 participants
Started: Oct 27, 2023 · Completed: Nov 1, 2026
1 condition
2 sponsors
1 location
NCT06008288
A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
PHASE2
Recruiting
88 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2027
3 conditions
1 sponsor
31 locations
NCT06119958
Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
PHASE1
Recruiting
32 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT06057350
Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR
NA
Recruiting
304 participants
Started: Oct 27, 2023 · Completed: Sep 30, 2033
2 conditions
13 sponsors
3 locations
NCT05914064
Gravitas Feeding Tube System Placement Validation in Neonates
NA
Recruiting
110 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT06492980
A Triple-branched Stent Graft for Aute Debakey Type I Dissection Surgery
NA
Recruiting
150 participants
Started: Oct 27, 2023 · Completed: Oct 10, 2025
1 condition
1 sponsor
1 location
NCT05918302
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
PHASE3
Recruiting
120 participants
Started: Oct 27, 2023 · Completed: Jul 31, 2028
3 conditions
3 sponsors
23 locations
NCT06319235
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®
PHASE1/PHASE2
Recruiting
52 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT06267131
Transcutaneous Pulse Oximetry Brain Monitoring Study (US)
NA
Recruiting
15 participants
Started: Oct 27, 2023 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT06254911
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
PHASE2
Recruiting
20 participants
Started: Oct 27, 2023 · Completed: Dec 16, 2026
1 condition
3 sponsors
1 location
NCT06044662
Prognostic Value of Biomarkers in Polyneuropathy.
N/A
Recruiting
200 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT06156956
Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol
NA
Recruiting
200 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
5 locations
NCT05900206
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
PHASE2
Recruiting
370 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2032
1 condition
1 sponsor
7 locations
NCT06155643
EKO SENSORA: Detecting Clinically Significant Murmurs
EARLY_PHASE1
Recruiting
300 participants
Started: Oct 26, 2023 · Completed: Jul 26, 2025
1 condition
1 sponsor
1 location
NCT05892614
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
PHASE2
Recruiting
25 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
15 locations
NCT06161922
Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy
N/A
Recruiting
600 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT05962450
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
PHASE2
Recruiting
84 participants
Started: Oct 26, 2023 · Completed: Aug 1, 2025
1 condition
2 sponsors
1 location
NCT05774652
LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers
NA
Recruiting
301 participants
Started: Oct 26, 2023 · Completed: Apr 1, 2026
5 conditions
6 sponsors
1 location
NCT06099756
Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)
N/A
Recruiting
2,000 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2024
1 condition
2 sponsors
3 locations
NCT05873686
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
PHASE1
Recruiting
140 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2027
6 conditions
1 sponsor
7 locations
NCT06054035
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
PHASE4
Recruiting
170 participants
Started: Oct 26, 2023 · Completed: Sep 30, 2027
3 conditions
4 sponsors
9 locations
NCT05923489
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
NA
Recruiting
2,618 participants
Started: Oct 26, 2023 · Completed: Oct 15, 2029
1 condition
9 sponsors
1 location
NCT06247605
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
PHASE3
Recruiting
243 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2029
1 condition
1 sponsor
1 location
NCT05655091
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
PHASE2
Recruiting
36 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06004856
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
PHASE3
Recruiting
195 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
45 locations
NCT05725655
Hot Water Immersion After Myocardial Infarction
NA
Recruiting
30 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05792007
Study of the Medullary Microenvironment in Acute Childhood Leukemia
NA
Recruiting
40 participants
Started: Oct 26, 2023 · Completed: Oct 24, 2028
2 conditions
1 sponsor
3 locations
NCT05848895
OPT-IN: Osteopathic Plagiocephaly Treatment for Infants and Neonates
NA
Recruiting
122 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06911697
Study on c-Met Targeted PET/CT Imaging in NSCLC
NA
Recruiting
88 participants
Started: Oct 26, 2023 · Completed: Jun 28, 2025
2 conditions
2 sponsors
1 location
NCT05984888
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
NA
Recruiting
43 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05929859
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
PHASE1/PHASE2
Recruiting
84 participants
Started: Oct 26, 2023 · Completed: Feb 29, 2028
1 condition
4 sponsors
1 location
NCT06066905
A Study of Chidamide With AZA in MRD Positive AML After Transplant
NA
Recruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06103201
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
PHASE1
Recruiting
15 participants
Started: Oct 26, 2023 · Completed: Nov 26, 2027
2 conditions
1 sponsor
1 location
NCT06049212
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
PHASE1
Recruiting
30 participants
Started: Oct 26, 2023 · Completed: Jan 29, 2027
5 conditions
1 sponsor
7 locations
NCT06106360
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
N/A
Recruiting
100 participants
Started: Oct 26, 2023 · Completed: Dec 26, 2025
2 conditions
1 sponsor
1 location
NCT06182696
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
PHASE1/PHASE2
Recruiting
83 participants
Started: Oct 26, 2023 · Completed: Aug 31, 2028
1 condition
1 sponsor
5 locations
NCT06143007
A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors
PHASE1
Recruiting
42 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
2 locations
NCT05935371
Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
N/A
Recruiting
87 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2025
7 conditions
2 sponsors
1 location
NCT05939999
Effects of Elastic Tape on Pulmonary Rehabilitation of Patients with Chronic Obstructive Pulmonary Disease
NA
Recruiting
42 participants
Started: Oct 26, 2023 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT06725758
Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours
PHASE1/PHASE2
Recruiting
315 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT07007741
Digital Therapy for Fatty Liver Disease
NA
Recruiting
120 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05799040
Evaluation of the Effectiveness of the Self-developed Pulmonary Lobar Ventilation Detector
N/A
Recruiting
40 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
Previous
1
More pages
684
685
686
687
688
689
690
More pages
1333
Next